Clinical Trial: Efficacy and Safety of Conventional Immunosuppressant Therapies in Elderly Patients With Neuromyelitis Optica Spectrum Disorder

U.S., June 24 -- ClinicalTrials.gov registry received information related to the study (NCT07032337) titled 'Efficacy and Safety of Conventional Immunosuppressant Therapies in Elderly Patients With Neuromyelitis Optica Spectrum Disorder' on April 24.

Brief Summary: Newly diagnosed NMOSD patients

Study Start Date: Jan. 01, 2011

Study Type: OBSERVATIONAL

Condition: Neuromyelitis Optica Spectrum Disorder (NMOSD)

Recruitment Status: COMPLETED

Sponsor: Samsung Medical Center

Information provided by (Responsible Party): Ju-Hong Min, Samsung Medical Center

Published by HT Digital Content Services with permission from Health Daily Digest....